Current Neuropharmacology
Title:ERRATUM
Volume: 10 Issue: 2
Export Options
About this article
Cite this article as:
ERRATUM, Current Neuropharmacology 2012; 10 (2) . https://dx.doi.org/10.2174/157015912800604524
DOI https://dx.doi.org/10.2174/157015912800604524 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
36
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Erythrocyte Amyloid Beta Peptide Isoform Distributions in Alzheimer and Mild Cognitive Impairment
Current Alzheimer Research Adam and Eve - The Story of Two Adolescents
Adolescent Psychiatry The Use of Nitric Oxide Synthase Inhibitors in Inflammatory Diseases: A Novel Class of Anti-Inflammatory Agents
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Polyglutamine Protein Trafficking and Neurodegeneration
Current Genomics Sexual Dimorphism in Autoimmune Disease
Current Molecular Medicine The Role of NF-κB Inhibitors in Cell Response to Radiation
Current Medicinal Chemistry Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
Current Molecular Medicine The Applicability of mTOR Inhibition in Solid Tumors
Current Cancer Drug Targets Depression as a Comorbidity in Behcet's Syndrome
CNS & Neurological Disorders - Drug Targets Disrupted Functional Connectivity Related to Differential Degeneration of the Cingulum Bundle in Mild Cognitive Impairment Patients
Current Alzheimer Research 1,4-Benzothiazines-A Biologically Attractive Scaffold
Mini-Reviews in Medicinal Chemistry Soluble Amyloid-β Levels and Late-Life Depression
Current Pharmaceutical Design Animal Models of Depressive Illness: The Importance of Chronic Drug Treatment
Current Pharmaceutical Design Mitochondrial Involvement in Psychiatric Illness in Adults
Current Psychiatry Reviews Quantitative Estimation of Software Quality in Hospital Information System
Neuroscience and Biomedical Engineering (Discontinued) The Role of Melatonin in Multiple Sclerosis, Huntington's Disease and Cerebral Ischemia
CNS & Neurological Disorders - Drug Targets Cardiovascular Risk and Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients on Therapy With Tolvaptan: A Pilot Study
Current Vascular Pharmacology Biomarker Discovery and Translation in Metabolomics
Current Metabolomics The Exploitation of Toll-like Receptor 3 Signaling in Cancer Therapy
Current Pharmaceutical Design Editorial [Hot topic: Transgenic Animal Models of Neurodegenerative Diseases (Guest Editor: Stephen D. Skaper)]
CNS & Neurological Disorders - Drug Targets